variable'. This definition implies that researchers can identify non-responders simply by looking at their data from a twocondition (control and exercise) experiment and concluding that those participants with a treatment − control difference close to zero or in the opposite direction to that expected are identified as 'non-responders' (the latter are sometimes labelled 'adverse responders'). The fallacy of this approach was hinted at by Barker and Schofield [2] , but the full implications of this issue were not explicitly described. We have provided a full account of the pitfalls in non-responder identification [3, 4] , and think that they can complement the useful review by Sparks [1] .
An observed response is comprised of the true response as well as random trial-to-trial within-individual variability [3] . Therefore, observed non-response to exercise, or any other treatment, does not necessarily mean that there has been a true non-response. In Fig. 1 , we present some simulated data that appears to show that individual participants differed substantially in terms of their acylated ghrelin response to exercise. It is well documented that exercise causes a reduction in the mean concentration of acylated ghrelin [5] . For the simulated data in Fig. 1 , the mean ± SD reduction in acylated ghrelin was 18.1 ± 23.1 pg/ml (95% CI 1.6, 34.7). Nevertheless, it appears as though there are four non-responders in this sample of ten participants, according to the definition provided in Dr Sparks' review [1] .
In reality, true individual differences in response to exercise do not exist in the data presented in Fig. 1 . In our simulation we subtracted exactly 25 pg/ml of ghrelin from each participant's control condition measurement. We then added the component of a typical magnitude of random trial-to-trial variability. The trial-to-trial correlation coefficient was 0.77 (95% CI 0.27, 0.94). This random variability in biological measurements from day-to-day or week-to-week is always present and uncontrollable. Importantly, it is this component of variance on its own that makes it look as though individual differences in exercise response exist, when this may not necessarily be so. Naturally, this component of variance can also influence the observed mean difference relative to the true mean difference, as it does in our data used to generate Fig.  1 (18.1 pg/ml vs 25 pg/ml, respectively).
For repeated trial studies, the optimal design for quantifying individual response differences is the replicate crossover design [6] . Here, the control and exercise conditions are actually administered to each participant at least twice, with the sequence of the four trials randomised. This design allows the researcher to derive the intervention × participant interaction term from the statistical model [6] , thereby enabling them to isolate the true individual differences in response to exercise. To our knowledge, this design has not yet been used in an exercise context, although we have several such studies ongoing at present.
Within-individual variability in the measured outcome also causes problems when interpreting the results of longer-term exercise training studies [3, 4] . In many of these studies, a control group is either not present or discarded in the data analysis. Plots of individual differences in baseline to follow up data are commonly presented for the exercise training arm only, as demonstrated in the upper graph of the figure in the review by Sparks [1] . Nevertheless, a very similar graph can usually also be plotted for the changes in baseline to follow up for the control group. These data are seldom presented but are crucial for ascertaining whether there are clinically relevant true individual differences in training response [3] .
In a parallel group study, true individual differences in exercise response are present only if the SD of change is substantially larger in the exercise group than the control group. If not, the apparent individual differences in response are nothing but baseline-to-follow-up within-individual variability, just as in Fig. 1 . This random variability can be large if there are many weeks (>6) between baseline and follow up in the study, and such longer-term durations of follow-up are commonly selected in studies. We also recently presented a critical review of a selected sample of exercise training studies; studies were included if the relevant data were reported and if the outcome was change in V O 2peak [4] . We found that very few studies included data from a control group in their analyses. For those studies that had a control group, we found little evidence that the difference in the SD of changes between intervention and control was clinically important, relative to an MCID of 1 metabolic equivalent (MET).
We maintain that ascertaining whether there are true individual differences in the responses to exercise that are large enough to be clinically relevant is a crucial platform for precision medicine. If these individual differences in response are found to be not clinically important, we question the need to proceed to explore individual moderators and mediators of response. Such explorations could be wasteful in terms of participant time as well as money from a funding body. We have also highlighted in this letter that an understanding of the impact of trial-to-trial or baseline-to-follow up variance is crucial for making robust inferences about individual response differences.
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